Clinical Trial Update: Application of the CD73-Targeted Probe ⁶⁸Ga-DOTA-mPNE PET/CT Imaging in the Diagnosis of Malignant Tumors [NA]

View source ↗

Summary

Clinical trial update evaluating a CD73-targeted PET/CT imaging probe, 68Ga-DOTA-mPNE, for diagnosing malignant tumors. The study, sponsored by Peking Union Med…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Brain Neoplasms

Drugs mentioned

• 68Ga-DOTA-mPNE (Gallium-68 DOTA-mPNE)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Malignant Neoplasms of Brain | NA | Status: RECRUITING